tiprankstipranks
Fractyl Health reports Q4 EPS (52c), consensus (44c)
PremiumThe FlyFractyl Health reports Q4 EPS (52c), consensus (44c)
29d ago
Fractyl Health price target lowered to $6 from $13 at BofA
Premium
The Fly
Fractyl Health price target lowered to $6 from $13 at BofA
2M ago
Premium
Company Announcements
Fractyl Health Reprioritizes Focus on REMAIN-1 Study
2M ago
Fractyl Health management to meet virtually with B. Riley
PremiumThe FlyFractyl Health management to meet virtually with B. Riley
4M ago
Fractyl Health management to meet virtually with B. Riley
Premium
The Fly
Fractyl Health management to meet virtually with B. Riley
4M ago
Premium
Company Announcements
Fractyl Health Reports Q3 2024 Financial Performance
5M ago
PremiumCompany AnnouncementsFractyl Health’s Revita System Wins FDA Breakthrough Designation
8M ago
Fractyl Health receives FDA BDD for Revita System
Premium
The Fly
Fractyl Health receives FDA BDD for Revita System
8M ago
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
Premium
The Fly
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100